Organisational Structure

Board of Directors

Global Health Initiative (Australia) is a not-for-profit organisation that was set up in 2019 in order for GHI to more readily operate out of Australia, including conducting its education events. The organisational structure of the Board of Directors is as follow:


Directors of Global Health Initiative Australia


Janelle Marsden

Kylie O’Brien

Jenny Junkeer


Janelle Marsden

Director of GHI Australia

Marsden has held senior roles across many industry sectors. Trained at a master’s level in construction, architecture and finance, she has been awarded senior roles over the past 20 years in both the public and private sector. Having lived in Australia, U.S. and Italy, Marsden has worked on large scale implementation projects and managed large agriculture developments. Marsden’s skills include agricultural grow, product implementation, organization and marketing. She has been the chair and board member of tourism, economic development and food and wine entities and has demonstrated her ability to drive and grow industries from the ground up. Marsden will also directly over see the infrastructure developments and ensure that Phoenix continues to meet its environmental, financial, timely and quality outcome.

As the Managing Director of Phoenix Life, Marsden manages the executive team to ensure they are on track to reach their individual and organizational goals, serves as the liaison between the company and new research opportunities and plays a pivotal role in company expansion.

Dr. Kylie O’Brien PhD


Director of GHI Australia


BSc(Optom), BAppSci (ChinMed), MPH, PhD (ChinMed), Grad Cert Tertiary Educ

Adjunct Professor Torrens University, Australia.

Fellow National Institute of Complementary Medicine (NICM) Health Research Institute.

Member Therapeutic Goods Administration (TGA) Advisory Committee for Complementary Medicines.

Member Tertiary Education Quality and Standards Agency (TEQSA) Expert Panel.

Originally trained as an optometrist, Kylie’s interest in public health began when she coordinated the world’s largest eye-camp at the time in rural India in 1991. She changed careers into Chinese medicine in the 1990’s, completing an undergraduate degree in Chinese medicine, Master of Public Health and in 2006, a PhD in Chinese Medicine (Monash University). In the early 2000s, she worked for health department in Victoria (Australia) on the implementation of the Chinese Medicine Act 2000, then moved into the tertiary education sector where she began teaching and eventually held senior academic positions in both universities and private education institutions. Her area of interest and expertise in health has spread beyond Chinese medicine to integrative medicine more broadly. She is a keen researcher and has supervised several postgraduate students. Prior research includes investigations into the efficacy of Chinese herbal medicines on cardiovascular risk factors and knee OA, as well as conducting the world’s first comprehensive investigation into the reliability of the CM diagnostic system. She has also developed UnityHealth’s Chinese herb-pharmaceutical interactions database, set for release in 2019/2020. She has authored numerous journal articles and book chapters on integrative medicine and Chinese medicine. Her first book O’Brien K, Sali A. A Clinician’s Guide to Integrative Oncology: What You Should Be Talking About with Cancer Patients and Why, was published in 2017 in the US by Springer.

Kylie’s passion has become medicinal cannabis. She has been leading the education of medical practitioners and allied healthcare practitioners in medicinal cannabis in Australia, developing the curricula for the first medicinal cannabis course to receive category CPD points from the Royal Australasian College of General Practitioners. Kylie is also actively involved in clinical research into hemp and medicinal cannabis. She is a member of the Australian Government’s Therapeutic Goods Administration’s Advisory Committee for Complementary Medicine, a member of the Australian Government’s Tertiary Education Quality and Standards Agency (TEQSA) Expert Panel, and a member of the World Federation of Chinese Medicine Societies’ Specialty Committee of Cancer Rehabilitation. Kylie is Adjunct Professor at Torrens University, and an Adjunct Fellow of the National Institute of Complementary Medicine (NICM) Health Research Institute, Western Sydney University, Australia.

Jenny Junkeer

Director of GHI Australia

Jenny is a Chartered Accountant with over fifteen years’ experience in corporate advisory and execution. She is a senior level business accelerator and scaling expert focused on redefining expectations of organisational performance. Based on years of working with a range of companies from SMEs to large multi-nationals, Jenny has become a thought leader in optimising organisation success. With the addition of project and change management capabilities, Jenny pairs strategy with execution to achieve transformational outcomes. Jenny has a strong passion to make a positive impact in the world through health and opportunity for people in need.

Advisory Board

The Global Health Initiative’s international Advisory Board is comprised of representatives from industry, consumer groups, healthcare practitioners, and academics/researchers. It meets at least four times per year to provide strategic advice on the activities of Global Health Initiative Foundation.

Professor Andrew Sinclair

B Agric Sci (University of Melbourne), PhD (Biochemistry) (University of Melbourne)

Emeritus Professor Andrew Sinclair holds a number of distinguished appointments including:

• Fellow Nutrition Society of Australia
• Fellow Australian Institute of Food Science & Technology
• Fellow Australian College of Nutritional & Environmental Medicine.,
• Emeritus Professor, Professor of Nutrition Science, Deakin University, Australia.
• Adjunct Professor, Department of Nutrition, Dietetics and Food, Monash University, Australia
• Visiting Professor, South China University of Technology, Guangzhou, China

Professor Sinclair has substantial experience in research, building multidisciplinary research teams, research advice, industry engagement, teaching and mentoring academics for fifty years, in working with industry in project management, provision of expert opinion evidence, senior advisor to industry boards, to international technical panels and academic journals.


Dr. Sinclair Bode


Dr. Bode graduated from medicine at Adelaide University in 1986 and has continuously undertaken further education including hypnotherapy, acupuncture, Chinese medicine and prolotherapy. He was introduced to Nutritional and Environmental Medicine in 1997 and this change in direction enabled him to further increase his repertoire of tools, to aid in the treatment of a variety of complex conditions. Dr Bode has lectured for ACNEM, Mindd, Cancer Care Centre, Chronic Fatigue Association and Autism SA (South Australia). He has worked as a Director, and an Integrative General Practitioner in the Adelaide Hills (Stirling) for many years. More recently Dr Bode has focused his practice on Integrative Medicine allowing him to again take new patients and to help more families confronted with complex medical problems. His areas of particular interests include, but are not limited to: autism, cancer, chronic fatigue, fibromyalgia, heavy metal toxicity, neurological conditions, mental health and complex medical problems. He has become experienced in prescribing medicinal cannabis since Australia legalised access in 2016.

Professor Ian Brighthope


Ian Brighthope has qualifications and experience in medicine, surgery, anaesthetics, agricultural science, research, nutritional medicine, environmental medicine, herbal medicine and education. He is the founding president of the Australasian College of Nutritional and Environmental Medicine (ACNEM). Professor Brighthope also pioneered the first post-graduate medical course in nutritional and environmental medicine in Australia. Nutrition Care Pharmaceuticals is a nutraceutical company that Professor Brighthope formed over 40 years ago. It is now a leading company in nutraceuticals in China.

Professor Brighthope is a strong advocate for professional freedoms for health care professionals and freedom of informed choice of treatment for patients. He has been extremely active in the medicinal cannabis industry, profession and government relations.

Carol Ireland

Consumer Representative

CEO and Managing Director of Epilepsy Action Australia (EAA), Carol has an extensive background spanning more than 35 years in the not-for-profit human services sector, holding a variety of executive positions. She has been at the forefront of the medical cannabis movement in Australia. In her role at Epilepsy Action Australia she has had significant contact with many individuals and families faced with managing very challenging forms of medication resistant epilepsy, with few or no options left in the conventional treatment bucket. Carol has heard and seen the changes in people’s lives, including reduction in the severity and frequency of seizures, resulting from use of medicinal cannabis. Carol serves on the Australian Advisory Council for the Use of Medicinal Cannabis, Advisory Board of The Lambert Initiative for Cannabinoid Therapeutics, Steering Committee for the NSW government’s Paediatric Epilepsy Trials (MC Research), and is a founding Director of the Medicinal Cannabis Council. She is a strong and active advocate for people living with epilepsy.

Dr. Santus Wari

MBBS, Grad Dip Gen Surgery

Dr Santos Wari graduated with a Bachelor of Medicine Bachelor of Surgery from the University of the South Pacific in Fiji and holds a postgraduate diploma in general surgery from the Fiji School of Medicine. He has been in clinical practice in surgery for over 25 years and is proficient in a wide range of areas within general surgery including head and neck, chest/thorax, abdomen, limbs, trauma and wound care. More specifically, his areas of specialty include plastic surgery, orthopaedics, paediatric surgery, obstetrics and gynaecology surgery and surgery in the following areas: neurology, spinal, hand, thyroid, breast, prostate, and bowel.
He was appointed Senior Consultant Surgeon for the Vanuatu Ministry of Health and has been Acting Consultant/Chief Surgeon on several occasions. Out of concerns for the quality of surgical services, he has been asked by the South Pacific Forum twice to contribute his views on the surgical services. This has spanned from medical syllabi, training and practice at service delivery taking Vanuatu as a case in time. He has worked as Medical Superintendent in the Vila Central Hospital and Northern Provincial Hospital in Vanuatu. He is now the Director of Curative and Hospital Services and Director General of Health, Ministry of Health, Vanuatu, and serves as Phoenix Life Sciences International Limited’s Head of National Healthcare for Vanuatu.